Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat prenatal corticosteroids in women still at risk of preterm birth before 32 weeks
ACTRN12606000318583Phase 3Completed
- Sponsor
- Professor Caroline Crowther
- Start
- Apr 1998
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of betamethasone sodium in preterm birth, sponsored by Professor Caroline Crowther. Primary endpoint: Neonatal lung disease. Started Apr 1998; status: completed.
02
Drugs
betamethasone sodium
03
Conditions
preterm birth
Beyond the preview
Go deeper on ACTRN12606000318583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000318583.